Taken together, our study suggests that leonurine may reduce the accumulation of lipids such as GPs and FAs in HFHSD-induced NAFLD mice, possibly by activating the ADRA1a/AMPK/SCD1 axis through the phosphorylation of AMPK protein. This evidence concerns the gene SCD and metabolic dysfunction-associated steatotic liver disease.